• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

InterSystems, Pulse InfoFrame Partner to Deliver ‘Patient Registry In A Box’

by HITC Staff 01/26/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Texas Taps InterSystems for Statewide Health Information Exchange

InterSystems has partnered with Pulse Infoframe, a collaborative research and patient registry solutions provider, to facilitate clinical research and population health studies. Leveraging the InterSystems HealthShare® health informatics platform for interoperability between clinical research systems and EHRs, physicians and researchers can easily capture, organize, model, store and share clinical research data through a secure, web-based application.

Healthie, the Pulse platform, is a clinical business intelligence solution that connects specialists from around the world in self-configuring networks. Created by physicians and for physicians, the cloud-based solution accepts and aggregates data from both mobile and stationary devices. The InterSystems HealthShare platform will ensure interoperability across a wide variety of health information systems and multiple geographies, enabling integration between the curated data collected in de-identified patient records and data from the research community, with real-time analytics.

For example, Pulse Infoframe created the first North American melanoma registry, now deployed in 12 leading cancer centers and growing. Dr. Scott Ernst, Division Head, Medical Oncology, at the London (Ontario) Health Science Centre, said, “We realized that even though we introduced new melanoma treatments, we were not always sure how we were impacting patient outcomes. Using Healthie, we can now track patients not just at our center, but all over the country, to answer that most basic of questions, ‘How are patients doing?’”

‘Outside-In’ Population Health
In another example, Pulse is working with a major U.S. metropolitan teaching hospital on a digital health program to develop online, mobile and software solutions to healthcare problems.

Dr. Robert L. Goodman, while serving as Professor of Radiation Oncology at Jefferson University Hospital, Philadelphia, worked with Pulse on this program to improve population health outcomes for over 100,000 labor union members in Philadelphia.

As a no-cost benefit, union members received a phone app that would identify potential risk for cardiovascular disease. The de-identified data could be accessed for population health studies by clinicians, and the union members who were identified as high risk could contact a physician for followup. “The participants can opt-in to get additional support and information if desired. Cardiologists can use the Pulse platform to push and pull data, combining public outreach with population health studies. The result is a healthier overall population,” Dr. Goodman noted.

“These ‘outside-in’ applications of our technology are very important,” Dr. Gwadry-Sridhar noted. “The data is based on a real-life population in which not everyone is sick, where the technology creates an opportunity for both cardio health education and ultimately wellness interventions.”

“We are proud to work with Pulse Infoframe. The Pulse platform could really be a real game changer in medicine, not only to facilitate collaborative research among clinicians and researchers, but to educate patients and maintain productive communications with them after treatment,” said Joe DeSantis, Vice President of HealthShare Platforms in a statement.

Today the Pulse platform is used by leading healthcare organizations worldwide to measure, value and improve patient outcomes for 24 diseases, including cancer, diabetes and heart disease. The solutions are replicable, quickly deployable and globally scalable.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |